Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NYSE - Nasdaq Real Time Price USD

Enzo Biochem, Inc. (ENZ)

0.3138
-0.0678
(-17.77%)
As of April 17 at 4:00:02 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
7/31/2024
7/31/2023
7/31/2022
7/31/2021
Total Revenue
29,094
31,907
31,061
32,643
117,731
Cost of Revenue
16,077
17,275
19,495
19,213
64,154
Gross Profit
13,017
14,632
11,566
13,430
53,577
Operating Expense
22,953
26,997
36,302
30,957
52,885
Operating Income
-9,936
-12,365
-24,736
-17,527
692
Net Non Operating Interest Income Expense
2,553
3,341
-1,122
178
8
Other Income Expense
-215
-793
836
-2,990
7,175
Pretax Income
-7,598
-9,817
-25,022
-20,339
7,875
Net Income Common Stockholders
-21,312
-26,078
20,288
-18,261
7,875
Diluted NI Available to Com Stockholders
-21,312
-26,078
20,288
-18,261
7,875
Basic EPS
-0.41
-0.51
0.41
-0.38
0.16
Diluted EPS
-0.41
-0.51
0.41
-0.38
0.16
Basic Average Shares
51,869
50,902
49,160
48,594
48,191
Diluted Average Shares
51,869
50,902
49,160
48,594
48,325
Total Operating Income as Reported
-9,936
-12,365
-24,736
-17,027
692
Total Expenses
39,030
44,272
55,797
50,170
117,039
Net Income from Continuing & Discontinued Operation
-21,312
-26,078
20,288
-18,261
7,875
Normalized Income
-7,299
-9,625
-26,302
-18,617
7,605
Interest Income
--
3,538
277
178
--
Interest Expense
--
197
1,399
--
--
Net Interest Income
2,553
3,341
-1,122
178
8
EBIT
-7,191
-9,620
-23,623
-17,527
692
EBITDA
-5,819
-8,348
-20,941
-14,700
3,345
Reconciled Cost of Revenue
16,077
17,275
19,495
19,213
64,154
Reconciled Depreciation
1,372
1,272
2,682
2,827
2,653
Net Income from Continuing Operation Net Minority Interest
-7,598
-9,817
-25,022
-20,339
7,875
Total Unusual Items Excluding Goodwill
-299
-192
1,280
-1,722
270
Total Unusual Items
-299
-192
1,280
-1,722
270
Normalized EBITDA
-5,520
-8,156
-22,221
-12,978
3,075
7/31/2021 - 6/12/1980

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PRPH ProPhase Labs, Inc.
0.3306
-6.39%
 
AWHL Aspira Women's Health Inc.
0.0350
+32.08%
 
NEOG Neogen Corporation
5.23
+6.20%
 
NG2.SG Neogen Corp
4.5600
+3.64%
 
STRRP Star Equity Holdings, Inc.
9.02
+0.10%
 
QIA.DE Qiagen N.V.
37.61
+0.17%
 
PRPO Precipio, Inc.
6.90
-10.45%
 
STRR Star Equity Holdings, Inc.
2.0146
+0.73%
 
NEO NeoGenomics, Inc.
10.11
+2.02%
 
XGN Exagen Inc.
5.84
+2.05%